Has GBL replaced GHB in recreational settings?

1Marinelli E, Beck R, Malvasi A, Lo Faro A, Zaami S. Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management. Arh Hig Rada Toksikol 2020;71:19–26. doi: 10.2478/aiht-2020-71-3314 Marinelli E Beck R Malvasi A Lo FaroA Zaami S Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management Arh Hig Rada Toksikol 20207119 26 10.2478/aiht-2020-71-3314783723732597141Open DOISearch in Google Scholar

2Busardò FP, Gottardi M, Tini A, Minutillo A, Sirignano A, Marinelli E, Zaami S. Replacing GHB with GBL in recreational settings: a new trend in chemsex. Curr Drug Metab 2018;19:1080–5. doi: 10.2174/13892002196661809 25090834 Busardò FP Gottardi M Tini A Minutillo A Sirignano A Marinelli E Zaami S Replacing GHB with GBL in recreational settings: a new trend in chemsex Curr Drug Metab 2018191080 5 10.2174/138920021966618092509083430251602Open DOISearch in Google Scholar

3Busardò FP, Vaiano F, Mannocchi G, Bertol E, Zaami S, Marinelli E. Twelve months monitoring of hair GHB decay following a single dose administration in a case of facilitated sexual assault. Drug Test Anal 2017;9:953–6. doi: 10.1002/dta.2100 Busardò FP Vaiano F Mannocchi G Bertol E Zaami S Marinelli E Twelve months monitoring of hair GHB decay following a single dose administration in a case of facilitated sexual assault Drug Test Anal 20179953 6 10.1002/dta.210027682186Open DOISearch in Google Scholar

4World Health Organization (WHO). γ-Butyrolactone (GBL). Who Expert Committee on Drug Dependence: thirty-fifth report. WHO Technical Report Series 973. Geneva: WHO; 2012. p. 14–5. World Health Organization (WHO) γ-Butyrolactone (GBL). Who Expert Committee on Drug Dependence: thirty-fifth report. WHO Technical Report Series 973 Geneva WHO 2012 p 14 5Search in Google Scholar

5Busardò FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome. Eur Rev Med Pharmacol Sci 2015;19:4654–63. PMID: 26698265 Busardò FP Kyriakou C Napoletano S Marinelli E Zaami S Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome Eur Rev Med Pharmacol Sci 2015194654 63 PMID: 26698265Search in Google Scholar

6McDonough M, Kennedy N, Glasper A, Bearn J. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 2004;75:3–9. doi: 10.1016/j.drugalcdep.2004.01.012 McDonough M Kennedy N Glasper A Bearn J Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review Drug Alcohol Depend 2004753 9 10.1016/j.drugalcdep.2004.01.01215225884Open DOISearch in Google Scholar

7Busardò FP, Bertol E, Vaiano F, Baglio G, Montana A, Barbera N, Zaami S, Romano G. Post mortem concentrations of endogenous gamma hydroxybutyric acid (GHB) and in vitro formation in stored blood and urine samples. Forensic Sci Int 2014;243:144–8. doi: 10.1016/j.forsciint.2014.07.019 Busardò FP Bertol E Vaiano F Baglio G Montana A Barbera N Zaami S Romano G Post mortem concentrations of endogenous gamma hydroxybutyric acid (GHB) and in vitro formation in stored blood and urine samples Forensic Sci Int 2014243144 8 10.1016/j.forsciint.2014.07.01925123534Open DOISearch in Google Scholar

8van Amsterdam J, Brunt T, Pennings E, van den Brink W. Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. Regul Toxicol Pharmacol 2014;70:507–13. doi: 10.1016/j.yrtph.2014.08.014 van AmsterdamJ Brunt T Pennings E van den Brink W Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB Regul Toxicol Pharmacol 201470507 13 10.1016/j.yrtph.2014.08.01425204614Open DOISearch in Google Scholar

9Busardò FP, Pichini S, Zaami S, Pacifici R, Kintz P. Hair testing of GHB: an everlasting issue in forensic toxicology. Clin Chem Lab Med 2018;56:198–208. doi: 10.1515/cclm-2017-0397 Busardò FP Pichini S Zaami S Pacifici R Kintz P Hair testing of GHB: an everlasting issue in forensic toxicology Clin Chem Lab Med 201856198 208 10.1515/cclm-2017-039728763296Open DOISearch in Google Scholar

10Kyriakou C, Pellegrini M, García-Algar O, Marinelli E, Zaami S. Recent trends in analytical methods to determine new psychoactive substances in hair. Curr Neuropharmacol 2017;15:663–81. doi: 10.2174/1570159X15666161111112545 Kyriakou C Pellegrini M García-Algar O Marinelli E Zaami S Recent trends in analytical methods to determine new psychoactive substances in hair Curr Neuropharmacol 201715663 81 10.2174/1570159X15666161111112545577104427834146Open DOISearch in Google Scholar

11Busardò FP, Kyriakou C, Tittarelli R, Mannocchi G, Pantano F, Santurro A, Zaami S, Baglìo G. Assessment of the stability of mephedrone in ante-mortem and post-mortem blood specimens. Forensic Sci Int 2015;256:28–37. doi: 10.1016/j. forsciint.2015.07.021 Busardò FP Kyriakou C Tittarelli R Mannocchi G Pantano F Santurro A Zaami S Baglìo G Assessment of the stability of mephedrone in ante-mortem and post-mortem blood specimens Forensic Sci Int 201525628 37 10.1016/j.forsciint.2015.07.02126295910Open DOISearch in Google Scholar

12Wood DM, Brailsford AD, Dargan PI. Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Test Anal 2011;3:417–25. doi: 10.1002/dta.292 Wood DM Brailsford AD Dargan PI Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) Drug Test Anal 20113417 25 10.1002/dta.29221548140Open DOISearch in Google Scholar

13Beck R, Matanović SM, Zibar L. Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat. Arh Hig Rada Toksikol 2019;70:149–50. doi: 10.2478/aiht-2019-70-3295 Beck R Matanović SM Zibar L Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat Arh Hig Rada Toksikol 201970149 50 10.2478/aiht-2019-70-329531246568Open DOISearch in Google Scholar